Texas Permanent School Fund cut its position in Mylan N.V. (NASDAQ:MYL) by 3.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 129,511 shares of the company’s stock after selling 5,048 shares during the period. Texas Permanent School Fund’s holdings in Mylan N.V. were worth $5,028,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in MYL. First Personal Financial Services raised its position in Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock worth $107,000 after buying an additional 681 shares during the last quarter. Global X Management Co. LLC raised its position in Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock worth $118,000 after buying an additional 1,441 shares during the last quarter. Ropes Wealth Advisors LLC purchased a new position in Mylan N.V. during the first quarter worth $136,000. Oakworth Capital Inc. raised its position in Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock worth $166,000 after buying an additional 1,000 shares during the last quarter. Finally, State of Alaska Department of Revenue purchased a new position in Mylan N.V. during the first quarter worth $188,000. Institutional investors own 71.57% of the company’s stock.
Shares of Mylan N.V. (NASDAQ:MYL) opened at 30.72 on Friday. Mylan N.V. has a 52-week low of $29.39 and a 52-week high of $49.09. The stock has a market capitalization of $16.47 billion, a price-to-earnings ratio of 24.83 and a beta of 1.27. The firm’s 50 day moving average is $36.12 and its 200 day moving average is $38.80.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://www.com-unik.info/2017/08/19/mylan-n-v-myl-stake-lowered-by-texas-permanent-school-fund-updated-updated.html.
MYL has been the topic of several research analyst reports. UBS AG reissued a “buy” rating and issued a $46.00 target price (down previously from $50.00) on shares of Mylan N.V. in a report on Thursday, August 10th. Citigroup Inc. raised shares of Mylan N.V. from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $36.00 to $42.00 in a report on Wednesday. Morgan Stanley lowered their target price on shares of Mylan N.V. from $52.00 to $36.00 and set an “equal weight” rating on the stock in a report on Monday, August 7th. Zacks Investment Research raised shares of Mylan N.V. from a “sell” rating to a “hold” rating in a report on Tuesday, June 20th. Finally, ValuEngine downgraded shares of Mylan N.V. from a “buy” rating to a “hold” rating in a research note on Wednesday, June 14th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Mylan N.V. presently has an average rating of “Buy” and an average price target of $47.73.
In related news, President Rajiv Malik sold 25,000 shares of Mylan N.V. stock in a transaction on Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $1,000,000.00. Following the transaction, the president now directly owns 799,855 shares in the company, valued at approximately $31,994,200. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Anthony Mauro sold 10,000 shares of Mylan N.V. stock in a transaction on Friday, June 9th. The shares were sold at an average price of $40.00, for a total value of $400,000.00. Following the transaction, the insider now owns 140,653 shares in the company, valued at approximately $5,626,120. The disclosure for this sale can be found here. 0.69% of the stock is owned by insiders.
About Mylan N.V.
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
What are top analysts saying about Mylan N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Mylan N.V. and related companies.